efavirenz
Generic: efavirenz
Labeler: xlcare pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
efavirenz
Generic Name
efavirenz
Labeler
xlcare pharmaceuticals inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
efavirenz 600 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72865-172
Product ID
72865-172_f21e4fb1-352d-7105-e053-2995a90a0588
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA078886
Listing Expiration
2026-12-31
Marketing Start
2021-05-29
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72865172
Hyphenated Format
72865-172
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
efavirenz (source: ndc)
Generic Name
efavirenz (source: ndc)
Application Number
ANDA078886 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 600 mg/1
Packaging
- 250 TABLET, FILM COATED in 1 BOTTLE (72865-172-25)
- 30 TABLET, FILM COATED in 1 BOTTLE (72865-172-30)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f21e4fb1-352d-7105-e053-2995a90a0588", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064", "N0000185504", "N0000182140", "N0000182141"], "upc": ["0372865172308"], "unii": ["JE6H2O27P8"], "rxcui": ["349477"], "spl_set_id": ["966b815d-1d78-4b54-8f00-c5a0b67c78be"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "manufacturer_name": ["XLCare Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "250 TABLET, FILM COATED in 1 BOTTLE (72865-172-25)", "package_ndc": "72865-172-25", "marketing_start_date": "20210529"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (72865-172-30)", "package_ndc": "72865-172-30", "marketing_start_date": "20210529"}], "brand_name": "EFAVIRENZ", "product_id": "72865-172_f21e4fb1-352d-7105-e053-2995a90a0588", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "72865-172", "generic_name": "EFAVIRENZ", "labeler_name": "XLCare Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EFAVIRENZ", "active_ingredients": [{"name": "EFAVIRENZ", "strength": "600 mg/1"}], "application_number": "ANDA078886", "marketing_category": "ANDA", "marketing_start_date": "20210529", "listing_expiration_date": "20261231"}